Cargando...
Using cheminformatics to predict cross reactivity of “designer drugs” to their currently available immunoassays
BACKGROUND: A challenge for drug of abuse testing is presented by ‘designer drugs’, compounds typically discovered by modifications of existing clinical drug classes such as amphetamines and cannabinoids. Drug of abuse screening immunoassays directed at amphetamine or methamphetamine only detect a s...
Gardado en:
| Main Authors: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
BioMed Central
2014
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4029917/ https://ncbi.nlm.nih.gov/pubmed/24851137 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1758-2946-6-22 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|